PRURIGO NODULARIS (PN)
Clinical trials for PRURIGO NODULARIS (PN) explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS (PN) trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS (PN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for relief from debilitating skin itch
Disease control Recruiting nowThis study is looking at how well the drug dupilumab works over time for people with a severe, itchy skin condition called prurigo nodularis. Researchers will follow 40 adults starting this treatment to see how much their itching and skin lesions improve. They will also collect b…
Matched conditions: PRURIGO NODULARIS (PN)
Sponsor: UMC Utrecht • Aim: Disease control
Last updated Apr 13, 2026 20:23 UTC
-
New pill aims to calm relentless itch of rare skin disease
Symptom relief Recruiting nowThis study tests an experimental drug called ICP-332 in 135 adults with prurigo nodularis, a condition causing intensely itchy skin bumps. Participants will receive either the drug or a placebo for 16 weeks. The main goal is to see if the drug reduces worst-itch scores and clears…
Matched conditions: PRURIGO NODULARIS (PN)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated May 07, 2026 18:42 UTC